TrialInternational immunopharmacology2022

Inactivated SARS-CoV-2 vaccines elicit immunogenicity and T-cell responses in people living with HIV.

Zhengchao Lv et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.